Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Investigate the Effect of S-Ketamine, as Pharmacological Model of Schizophrenia, on the Attentiveness and Working Memory Simultaneously Measured With Functional Magnetic Resonance Imaging(fMRI)/Electroencephalogram(EEG)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01165294

Organisation Name: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Overal Status: Completed

Start Date: October 2009

Last Update: August 6, 2010

Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Brief Summary: The objective of this study is to develop an exploratory design for future Proof-of-Concept trials which reliably and accurately measure the central nervous system (CNS) effects of potentially new drugs that oppose the effects of ketamine at a subanesthetic dose level given to healthy volunteers. A functional magnetic resonance imaging (fMRI) and electroencephalogram (EEG) performed simultaneously during a ketamine challenge will register the effects triggered by Ketamine.

Conditions:
  • Schizophrenia


Total execution time in seconds: 0.15174603462219